Monitor for any selling stockholder notices of intent to sell or actual sales under the shelf. The 923,827 shares represent potential dilution of approximately 5-10% of current outstanding shares (based on prior filings). Watch for warrant exercise announcements, which would provide cash but increase share count.
Price Chart
Executive Summary
The SEC declared effective Lexaria Bioscience Corp.'s S-3 shelf registration (File No. 333-299257) on October 13, 2026. This allows the resale of up to 923,827 shares of common stock by selling stockholders, including shares underlying Series A and Series B warrants and placement agent warrants, with potential aggregate cash proceeds of $11,760,182 upon exercise. The effectiveness creates a near-term overhang of potential dilution, though the company receives no proceeds from the resale itself.
Key Facts
- S-3 registration declared effective on October 13, 2026 (File No. 333-299257).
- Covers resale of up to 923,827 shares of common stock by selling stockholders.
- Shares include 453,969 shares from Series A warrants, 453,969 from Series B warrants, and 15,889 from placement agent warrants.
- Potential aggregate cash proceeds to the company of $11,760,182 upon warrant exercise.
- Company receives no proceeds from the resale itself; proceeds only if warrants are exercised for cash.
- S-3 was filed on October 1, 2026, and became effective in 12 days.
Financial Impact
Up to 923,827 shares of common stock registered for resale; potential cash proceeds of $11,760,182 upon warrant exercise.
Risk Factors
- Near-term dilution from resale of registered shares.
- Warrant exercise may not occur, limiting cash inflow.
- Shelf registration allows continuous selling pressure without further disclosure.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003231 |
| Document: 9999999995-26-003231-index.html | 9999999995-26-003231 |
| Document: 9999999995-26-003231.txt | 9999999995-26-003231 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | EFFECT | $2.82 $2.99 | ▼ −6.03% | ▼ −5.74% | $2.92 (−3.55%) |
Oct 1, 2026 24d ago | S-3 | $2.88 $2.77 | ▲ +3.82% | ▲ +4.49% | $2.92 (−1.39%) |
Sep 1, 2026 7w ago | 8-K | $12.48 $13.21 | ▲ +5.85% | ▲ +5.41% | $2.92 (−76.59%) |
Aug 10, 2026 11w ago | 8-K | $5.79 $6.12 | ▼ −5.70% | ▼ −5.45% | $2.92 (+49.57%) |
Jul 30, 2026 12w ago | 8-K | $0.3963 $0.3910 | ▼ −1.34% | ▼ −2.06% | $2.92 (+636.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers